These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 11727721
1. Principles of pharmaceutical management of spastic hypertonia. Elovic E. Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):793-816, vii. PubMed ID: 11727721 [Abstract] [Full Text] [Related]
3. Botulinum neurotoxin intramuscular chemodenervation. Role in the management of spastic hypertonia and related motor disorders. Yablon SA. Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):833-74, vii-viii. PubMed ID: 11723867 [Abstract] [Full Text] [Related]
5. [Management of spasticity in children with cerebral palsy]. Matthews DJ, Balaban B. Acta Orthop Traumatol Turc; 2009 Nov; 43(2):81-6. PubMed ID: 19448346 [Abstract] [Full Text] [Related]
6. Drug treatments for spasticity. Yelnik AP, Simon O, Bensmail D, Chaleat-Valayer E, Decq P, Dehail P, Quentin V, Marque P, Parratte B, Pellas F, Rousseaux M, Trocello JM, Uzzan M, Dumarcet N, Agence française de sécurité sanitaire des produits de santé. Ann Phys Rehabil Med; 2009 Dec; 52(10):746-56. PubMed ID: 19892619 [No Abstract] [Full Text] [Related]
7. Intrathecal baclofen therapy for spastic hypertonia. Ivanhoe CB, Tilton AH, Francisco GE. Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):923-38, viii-ix. PubMed ID: 11727722 [Abstract] [Full Text] [Related]
8. Pharmacotherapy of spasticity in children with cerebral palsy. Verrotti A, Greco R, Spalice A, Chiarelli F, Iannetti P. Pediatr Neurol; 2006 Jan; 34(1):1-6. PubMed ID: 16376270 [Abstract] [Full Text] [Related]
9. [Medical treatment of spasticity]. Rode G, Maupas E, Luaute J, Courtois-Jacquin S, Boisson D. Neurochirurgie; 2003 May; 49(2-3 Pt 2):247-55. PubMed ID: 12746699 [Abstract] [Full Text] [Related]
10. [Botulin toxin for spasticity in spinal cord damage by treating the motor endplate]. Keren O, Shinberg F, Catz A, Giladi N. Harefuah; 2000 Feb 01; 138(3):204-8, 270. PubMed ID: 10883093 [Abstract] [Full Text] [Related]
11. [Spastic syndrome and main directions of its treatment]. Damulin IV. Zh Nevrol Psikhiatr Im S S Korsakova; 2003 Feb 01; 103(12):4-9. PubMed ID: 14763249 [No Abstract] [Full Text] [Related]
12. Pharmacologic treatment of spasticity in children. Tilton A, Vargus-Adams J, Delgado MR. Semin Pediatr Neurol; 2010 Dec 01; 17(4):261-7. PubMed ID: 21183133 [Abstract] [Full Text] [Related]
13. [Spasticity and botulinum toxin in 2003. An update]. Fève A. Neurochirurgie; 2003 May 01; 49(2-3 Pt 2):265-70. PubMed ID: 12746701 [Abstract] [Full Text] [Related]
14. Intrathecal clonidine for controlling spastic hypertonia. Rémy-Néris O, Denys P, Bussel B. Phys Med Rehabil Clin N Am; 2001 Nov 01; 12(4):939-51, ix. PubMed ID: 11723871 [Abstract] [Full Text] [Related]
15. Botulinum toxin for the management of adult patients with upper motor neuron syndrome. Esquenazi A, Mayer NH, Elia AE, Albanese A. Toxicon; 2009 Oct 01; 54(5):634-8. PubMed ID: 19470335 [Abstract] [Full Text] [Related]
16. Anti-spasticity medications. Al-Shahrani AM. Saudi Med J; 2003 Jan 01; 24(1):19-22. PubMed ID: 12590267 [Abstract] [Full Text] [Related]
17. [Meningitis due to Escherichia coli as a delayed complication of intrathecal baclofen pump systems]. Pérez-Quesada S, Martín-Estefanía C, Martí-Martínez S, Turpín-Fenoll L. Rev Neurol; 2003 Jan 01; 42(12):764-6. PubMed ID: 16775804 [No Abstract] [Full Text] [Related]
18. Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Gracies JM, Nance P, Elovic E, McGuire J, Simpson DM. Muscle Nerve Suppl; 1997 Jan 01; 6():S92-120. PubMed ID: 9826984 [Abstract] [Full Text] [Related]